Stanford University
Showing 111-120 of 193 Results
-
Hieu Minh Nguyen
Lecturer
BioHieu Minh Nguyen is the author of two collections of poetry, This Way to the Sugar (Write Bloody Press, 2014), and Not Here (Coffee House Press, 2018), which was named the winner of the Publishing Triangle's Thom Gunn Award for Gay Poetry. A recipient of the Ruth Lilly and Dorothy Sargent Rosenberg Fellowship from the Poetry Foundation, Hieu is also a 2018 McKnight Writing Fellow, a Kundiman Fellow, and a 2017 National Endowment for the Arts Literature Fellow. His work has appeared in Poetry Magazine, Best American Poetry, The New York Times, and elsewhere. He is a graduate of the MFA Program for Writers at Warren Wilson College. Originally from the Twin Cities, Hieu now lives in Oakland.
-
Judy Nguyen, MD
Clinical Assistant Professor, Radiology - Rad/Nuclear Medicine
BioI am originally from San Diego, California where I attended medical school and did a surgical internship at UCSD. While there, I was exposed to the field of Nuclear Medicine and became fascinated by molecular imaging and the burgeoning field of theragnostics. I chose the Nuclear Medicine residency program at Stanford because it is one of the premier molecular imaging programs in the world, where some of the best known physicians and scientists in the field are located. Situated in Silicon Valley and rooted in a culture of collaboration, Stanford reaps the benefits from being at the intersection of technology, innovation, engineering and science to produce ground breaking research that continually pushes the imagination and limits of Nuclear Medicine. I am honored to be able to pursue my clinical interests and further my career in this environment.
-
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders.
